HomeCompareCLIUF vs MRK

CLIUF vs MRK: Dividend Comparison 2026

CLIUF yields 8.43% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CLIUF wins by $5.82M in total portfolio value
10 years
CLIUF
CLIUF
● Live price
8.43%
Share price
$5.10
Annual div
$0.43
5Y div CAGR
52%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.88M
Annual income
$4,341,955.02
Full CLIUF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — CLIUF vs MRK

📍 CLIUF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCLIUFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CLIUF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CLIUF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLIUF
Annual income on $10K today (after 15% tax)
$716.67/yr
After 10yr DRIP, annual income (after tax)
$3,690,661.77/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, CLIUF beats the other by $3,682,065.05/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLIUF + MRK for your $10,000?

CLIUF: 50%MRK: 50%
100% MRK50/50100% CLIUF
Portfolio after 10yr
$2.97M
Annual income
$2,176,034.40/yr
Blended yield
73.29%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CLIUF
No analyst data
Altman Z
8.7
Piotroski
5/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLIUF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCLIUFMRK
Forward yield8.43%2.81%
Annual dividend / share$0.43$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR52%32.7%
Portfolio after 10y$5.88M$57.7K
Annual income after 10y$4,341,955.02$10,113.78
Total dividends collected$5.71M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CLIUF vs MRK ($10,000, DRIP)

YearCLIUF PortfolioCLIUF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,982$1,281.57$11,213$373.04+$769.00CLIUF
2$15,002$2,181.30$12,667$512.06+$2.3KCLIUF
3$19,931$3,879.70$14,439$708.14+$5.5KCLIUF
4$28,649$7,322.49$16,640$988.16+$12.0KCLIUF
5$45,606$14,951.74$19,432$1,394.07+$26.2KCLIUF
6$82,610$33,811.57$23,057$1,992.90+$59.6KCLIUF
7$175,396$87,003.11$27,889$2,894.79+$147.5KCLIUF
8$450,084$262,410.05$34,518$4,286.29+$415.6KCLIUF
9$1,438,153$956,563.49$43,912$6,494.35+$1.39MCLIUF
10$5,880,779$4,341,955.02$57,714$10,113.78+$5.82MCLIUF

CLIUF vs MRK: Complete Analysis 2026

CLIUFStock

City of London Investment Group PLC is a publically owned investment manager. The firm provides client focused equity portfolios. It invests in public equity markets across the globe. The firm invests in small cap companies in emerging markets to create its portfolios. It uses combination of macroeconomic, qualitative, and top down company analysis to make its investments. The firm uses in house research to make its investments. It benchmarks the performance of its portfolios with S&P EM Frontier Super Comp., MSCI Emerging Markets Index, HSBC Global Mining Index, and MSCI ACWI ex US Index. City of London Investment Group PLC was founded in 1991 and is based in London, United Kingdom with additional offices in Dubai, United Arab Emirates, Singapore, Coatesville, Pennsylvania, Bellevue, Washington.

Full CLIUF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CLIUF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLIUF vs SCHDCLIUF vs JEPICLIUF vs OCLIUF vs KOCLIUF vs MAINCLIUF vs JNJCLIUF vs ABBVCLIUF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.